Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Immunology·MeSH: Arthritis, Juvenile
Prevalence
75.0 / 100K
5 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Polyarticular Course Juvenile Idiopathic Arthritis (JIA)?
BioSniper tracks 5 drugs in development for Polyarticular Course Juvenile Idiopathic Arthritis (JIA) across 3 companies.
How many clinical trials target Polyarticular Course Juvenile Idiopathic Arthritis (JIA)?
There are 1 clinical trial targeting Polyarticular Course Juvenile Idiopathic Arthritis (JIA) tracked by BioSniper.
What is the prevalence of Polyarticular Course Juvenile Idiopathic Arthritis (JIA)?
The estimated prevalence of Polyarticular Course Juvenile Idiopathic Arthritis (JIA) is approximately 75.0 per 100,000 population.
Deep-dive into Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis